
  
    
      
        Introduction_NNP
        Postoperative_NNP morbidity_NN and_CC mortality_NN after_IN
        hepatobiliary_JJ operations_NNS ,_, especially_RB in_IN cancer_NN patients_NNS ,_,
        has_VBZ traditionally_RB been_VBN perceived_VBN as_IN being_VBG high_JJ ._. Prior_RB
        reports_VBZ ,_, however_RB ,_, have_VBP failed_VBN to_TO identify_VB a_DT predominant_NN
        class_NN of_IN complications_NNS ,_, such_JJ that_IN interventions_NNS could_MD be_VB
        undertaken_VBN that_WDT might_MD be_VB able_JJ to_TO reduce_VB the_DT incidence_NN of_IN
        these_DT complications_NNS ._. Prior_RB reports_VBZ have_VBP focused_VBN on_IN
        subgroups_NNS of_IN operations_NNS within_IN the_DT family_NN of_IN all_DT
        hepatobiliary_JJ procedures_NNS ,_, such_JJ as_IN hepatic_JJ resection_NN [_NN 1_CD ,_, 2_CD ,_,
        3_CD ,_, 4_CD ,_, 5_CD ]_NN ,_, proximal_NN bile_NN duct_NN resection_NN [_NN 6_CD ,_, 7_CD ]_NN ,_, pancreatic_JJ
        resection_NN [_NN 8_CD ,_, 9_CD ]_NN ,_, and_CC biliary-enteric_JJ bypass_NN [_NN 10_CD ]_NN ._. There_EX
        are_VBP no_DT prior_JJ reports_VBZ on_IN the_DT utilization_NN and_CC outcomes_NNS of_IN
        critical_JJ care_NN services_NNS required_VBN in_IN the_DT management_NN of_IN all_DT
        patients_NNS who_WP experience_VBP complications_NNS after_IN hepatobiliary_JJ
        surgery_NN at_IN a_DT single_JJ institution_NN ._. This_DT paper_NN reviews_VBZ the_DT
        complications_NNS leading_VBG to_TO the_DT utilization_NN of_IN critical_JJ care_NN
        services_NNS after_IN all_DT hepatobiliary_JJ procedures_NNS performed_VBN over_IN
        a_DT 23_CD -_: month_NN period_NN by_IN a_DT team_NN of_IN specialized_JJ surgeons_NNS ,_,
        nurses_NNS ,_, anesthesiologists_NNS ,_, and_CC internists_NNS who_WP comprise_VBP the_DT
        Hepatobiliary_NNP Disease_NNP Management_NNP Team_NNP of_IN the_DT Memorial_NNP
        Sloan-_NNP Kettering_NNP Cancer_NNP Center_NNP ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Statistical_NNP analysis_NN
          Results_NNS are_VBP expressed_VBN as_IN the_DT mean_JJ ±_NN standard_JJ
          deviation_NN ,_, median_JJ (_( range_NN )_) ,_, or_CC as_IN the_DT number_NN and_CC percentage_NN
          of_IN the_DT total_JJ number_NN of_IN patients_NNS forcategoric_JJ variables_NNS ._.
          One-way_NNP analysis_NN of_IN variance_NN was_VBD used_VBN for_IN comparison_NN
          ofall_NN continuous_JJ variables_NNS ._. Pearson_NNP 's_POS χ_NN 2_CD analysis_NN
          orFisher_NN 's_POS exact_JJ test_NN ,_, when_WRB appropriate_JJ ,_, were_VBD used_VBN for_IN
          univariatecomparisons_NNS for_IN all_DT categoric_JJ variables_NNS
          analyzed_VBD ._. When_WRB multiple_JJ categoricvariables_NNS were_VBD
          determined_VBN to_TO be_VB statistically_RB significant_JJ by_IN
          univariateanalysis_NNS ,_, they_PRP were_VBD then_RB entered_VBN into_IN a_DT
          logistic_JJ regression_NN model_NN formultivariate_NN analysis_NN to_TO
          determine_VB independent_JJ predictors_NNS of_IN outcome_NN ._. Thesoftware_NNP
          program_NN SPSS_NNP for_IN Windows_NNP (_( version_NN 8_CD ._. 0_CD ;_: SPSS_NNP Incorporated_NNP ,_,
          Chicago_NNP ,_, Illinois_NNP ,_, USA_NNP )_) was_VBD utilized_JJ for_IN all_DT statistical_JJ
          analyses_NNS ._. 
          P_NN ≤_NN 0_CD ._. 05_CD was_VBD considered_VBN
          statistically_RB significant_JJ ._.
        
      
      
        Results_NNS
        
          Study_NN population_NN
          Between_IN February_NNP 2_CD ,_, 1994_CD and_CC December_NNP 28_CD ,_, 1995_CD ,_, 1048_CD
          patients_NNS wereadmitted_JJ to_TO the_DT Hepatobiliary_NNP Surgical_NNP
          Service_NNP (_( admitting_VBG physicians_NNS LHB_NNP andYF_NN )_) at_IN Memorial_NNP
          Sloan-_NNP Kettering_NNP Cancer_NNP Center_NNP ._. Of_IN these_DT ,_, 32_CD out_IN of_IN 537_CD
          patients_NNS (_( 6_CD ._. 0_CD %_NN )_) undergoing_VBG surgical_JJ treatment_NN were_VBD
          admitted_VBN to_TO the_DT SCU_NNP ,_, whereas_IN four_CD outof_NN 511_CD patients_NNS
          (_( 0_CD ._. 8_CD %_NN )_) who_WP were_VBD receiving_VBG medical_JJ treatment_NN only_RB were_VBD
          admittedto_NN the_DT SCU_NNP ._. No_DT single_JJ surgical_JJ procedure_NN was_VBD
          associated_VBN with_IN a_DT higher_JJR frequencyof_NN SCU_NNP utilization_NN than_IN
          other_JJ procedures_NNS (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          Preoperative_NNP variables_NNS
          The_DT mean_JJ age_NN of_IN the_DT 32_CD patients_NNS (_( 22_CD males_NNS ,_, 10_CD females_NNS )_)
          admitted_VBN tothe_NN SCU_NNP for_IN postoperative_JJ care_NN was_VBD 63_CD ._. 2_LS ±_NN 12_CD ._. 2_LS
          years_NNS (_( median_JJ 66_CD years_NNS ,_, range_NN 30_CD -_: 84_CD years_NNS )_) ._. The_DT admitting_VBG
          diagnoses_NNS are_VBP summarized_VBD in_IN Table_NNP 1_CD ._. Eighteen_CD patients_NNS
          had_VBD a_DT history_NN of_IN cardiac_JJ disease_NN ,_, 10_CD werejaundiced_JJ in_IN the_DT
          preoperative_JJ period_NN ,_, 10_CD underwent_VBD preoperative_JJ
          biliaryinstrumentation_NN ,_, nine_CD underwent_VBD preoperative_JJ
          biliary_JJ drainage_NN ,_, five_CD had_VBD ahistory_NN of_IN cirrhosis_NNS and_CC /_NN or_CC
          portal_NN hypertension_NN ,_, four_CD had_VBD a_DT history_NN of_IN
          chronicobstructive_JJ pulmonary_JJ disease_NN ,_, and_CC three_CD had_VBD a_DT
          history_NN of_IN viral_JJ hepatitis_NN ._.
          Mean_VB preoperative_JJ laboratory_NN values_NNS of_IN those_DT 32_CD
          patients_NNS admitted_VBD tothe_NN SCU_NNP for_IN postoperative_JJ care_NN were_VBD
          as_IN follows_VBZ :_: albumin_NN 3_CD ._. 5_CD ±_NN 0_CD ._. 7_CD g_SYM /_NN dl_NN (_( normal_JJ range_NN 4_CD ._. 0_CD -_: 5_CD ._. 2_LS
          g_SYM /_NN dl_NN )_) ,_, prothrombin_NN time_NN 12_CD ._. 6_CD ±_NN 1_CD ._. 1_CD s_VBZ (_( normal_JJ
          range_NN <_NN 13_CD ._. 1_LS s_VBZ )_) ,_, total_JJ bilirubin_NN 3_CD ._. 5_CD ±_NN 6_CD ._. 4_CD mg_NN /_NN dl_NN (_( normal_JJ
          range_NN 0_CD -_: 1_CD ._. 0_CD mg_NN /_NN dl_NN )_) ,_, creatinine_NN 1_CD ._. 1_CD ±_NN 0_CD ._. 3_CD mg_NN /_NN dl_NN (_( normal_JJ
          range_NN 0_CD ._. 6_CD -_: 1_CD ._. 3_LS mg_NN /_NN dl_NN )_) ,_, and_CC white_JJ blood_NN cellcount_NN 9228_CD ±_NN
          6452_CD cells_NNS /_NN mm_NN 3_CD (_( normal_JJ range_NN 5000_CD -_: 10000_CD cell_NN /_NN mm_NN 3_LS )_) ._.
        
        
          Operative_NNP variables_NNS
          A_DT summary_NN of_IN the_DT operations_NNS performed_VBN on_IN those_DT 32_CD
          patients_NNS admittedpostoperatively_RB to_TO the_DT SCU_NNP is_VBZ shown_VBN in_IN
          Table_NNP 2_CD ._. Twenty-six_NNP patients_NNS were_VBD operated_VBN upon_IN electively_RB
          and_CC six_CD patients_NNS emergently_RB ._. Sixteen_NNP patients_NNS underwent_VBD
          resection_NN of_IN malignant_JJ disease_NN with_IN curative_JJ intent_NN ,_, six_CD
          underwent_VBD treatment_NN for_IN benign_JJ disease_NN ,_, six_CD had_VBD
          palliative_JJ operations_NNS ,_, andfour_NN received_VBD treatment_NN for_IN
          complications_NNS of_IN a_DT surgical_JJ procedure_NN performedduring_VBG a_DT
          previous_JJ hospital_NN admission_NN ._. Mean_VB operating_VBG time_NN was_VBD 232_CD
          ±_NN 116_CD min_NN (_( median_JJ 210_CD min_NN ,_, range_NN 37_CD -_: 493_CD min_NN )_) ,_, mean_VB
          intraoperative_JJ blood_NN loss_NN was_VBD 2064_CD ±_NN 2271_CD cm_NN 3_CD (_( median_JJ 1100_CD
          cm_NN 3_CD ,_, range_NN 0_CD -_: 9000_CD cm_NN 3_LS )_) ,_, mean_VB transfusion_NN of_IN red_JJ blood_NN
          cells_NNS was_VBD 3_CD ._. 4_CD ±_NN 4_CD ._. 7_CD units_NNS (_( median_JJ 2_CD units_NNS ,_, range_NN 0_CD -_: 18_CD
          units_NNS )_) ,_, and_CC mean_VB intraoperative_JJ fluid_JJ administration_NN was_VBD
          5369_CD ±_NN 3922_CD cm_NN 3_CD (_( median_JJ 4300_CD cm_NN 3_CD ,_, range_NN 400_CD -_: 20600_CD cm_NN
          3_LS )_) ._. During_IN their_PRP$ postoperative_JJ course_NN ,_, seven_CD patients_NNS
          required_VBD second_JJ procedures_NNS (_( two_CD drainage_NN intraabdominal_NN
          abscesses_NNS ,_, two_CD tracheostomies_NNS ,_, one_CD repair_NN ofbleeding_VBG
          peptic_JJ ulcer_NN ,_, one_CD repair_NN of_IN postoperative_JJ intraabdominal_NN
          bleed_VB ,_, onerepeat_NN pancreatic_JJ debridement_NN )_) ,_, two_CD patients_NNS
          required_VBD a_DT third_JJ procedure_NN (_( onerepeat_NN pancreatic_JJ
          debridement_NN ,_, one_CD removal_NN of_IN intra-abdominal_JJ packing_NN
          andclosure_NN of_IN abdomen_NN )_) ,_, and_CC one_CD patient_NN required_VBD a_DT fourth_JJ
          procedure_NN (_( thoracotomy_NN /_NN decortication_NN for_IN empyema_NN )_) ._.
        
        
          Postoperative_NNP variables_NNS and_CC complications_NNS
          The_DT mean_JJ total_JJ stay_NN in_IN the_DT SCU_NNP was_VBD 11_CD ._. 2_LS ±_NN 17_CD ._. 6_CD days_NNS
          (_( median_JJ 4_CD ._. 5_LS days_NNS ,_, range_NN 1_CD -_: 78_CD days_NNS )_) ._. The_DT mean_JJ postoperative_JJ
          duration_NN of_IN hospital_NN stay_NN was_VBD 28_CD ._. 2_LS ±_NN 36_CD ._. 3_LS days_NNS (_( median_JJ
          15_CD ._. 5_LS days_NNS ,_, range_NN 4_CD -_: 177_CD days_NNS )_) ._. Twenty-one_CD patientswere_NN
          admitted_VBN to_TO the_DT SCU_NNP directly_RB from_IN the_DT operating_VBG room_NN ,_, or_CC
          the_DT followingmorning_VBG from_IN the_DT PACU_NNP ._. The_DT reason_NN for_IN
          admission_NN to_TO the_DT SCU_NNP in_IN these_DT 21_CD patientswas_NNS inability_NN to_TO
          wean_VB from_IN the_DT ventilator_NN (_( 
          n_NN =_SYM 10_CD )_) ,_, hypovolemic_JJ shock_NN (_( 
          n_NN =_SYM 4_LS )_) ,_, myocardial_NN
          ischemia_NN /_NN infarction_NN (_( 
          n_NN =_SYM 2_LS )_) ,_, ongoing_JJ septicshock_NN (_( 
          n_NN =_SYM 2_LS )_) ,_, ongoing_JJ upper_JJ
          gastrointestinal_NN bleeding_VBG (_( 
          n_NN =_SYM 2_LS )_) ,_, and_CC acute_JJ renal_JJ failure_NN (_( 
          n_NN =_SYM 1_LS )_) ._. Eleven_CD patients_NNS were_VBD
          admitted_VBN to_TO theSCU_NN from_IN floor_NN care_NN at_IN a_DT later_JJ time_NN during_IN
          their_PRP$ postoperative_JJ course_NN ._. Thereasons_NNP for_IN admission_NN to_TO
          the_DT SCU_NNP in_IN these_DT 11_CD patients_NNS were_VBD respiratory_JJ failure_NN (_( 
          n_NN =_SYM 4_LS )_) ,_, cardiac_JJ
          dysrhythmia_NN /_NN infarction_NN (_( 
          n_NN =_SYM 4_LS )_) ,_, septic_JJ shock_NN (_( 
          n_NN =_SYM 2_LS )_) ,_, and_CC upper_JJ gastrointestinal_NN
          bleeding_VBG (_( 
          n_NN =_SYM 1_LS )_) ._. Tenpatients_NNP required_VBD
          readmission_NN to_TO the_DT SCU_NNP after_IN being_VBG transferred_VBN to_TO floor_NN
          care_NN (_( five_CD because_IN of_IN upper_JJ gastrointestinal_NN bleeding_NN ,_,
          five_CD because_IN of_IN respiratoryfailures_NNS )_) ,_, four_CD patients_NNS
          required_VBD a_DT third_JJ SCU_NNP admission_NN (_( all_DT because_IN ofrespiratory_NN
          failures_NNS )_) ,_, and_CC two_CD patients_NNS requiring_VBG a_DT fourth_JJ SCU_NNP
          admission_NN (_( bothbecause_NN of_IN intra-abdominal_JJ
          abscesses_NNS /_NN sepsis_NN )_) ._. A_DT comprehensive_JJ list_NN of_IN
          allpostoperative_JJ complications_NNS seen_VBN is_VBZ shown_VBN in_IN Table_NNP
          3_CD ._.
        
        
          High_NNP and_CC low_JJ postoperative_JJ laboratory_NN values_NNS
          Mean_VB high_JJ and_CC low_JJ postoperative_JJ laboratory_NN values_NNS of_IN
          the_DT 32_CD patientsadmitted_JJ to_TO the_DT SCU_NNP in_IN the_DT postoperative_JJ
          period_NN and_CC the_DT mean_NN days_NNS on_IN which_WDT theyoccurred_JJ were_VBD as_IN
          follows_VBZ :_: lowest_JJS albumin_NN value_NN 2_CD ._. 1_CD ±_NN 0_CD ._. 4_CD g_SYM /_NN dl_NN on_IN day_NN 13_CD (_( ±_NN
          25_CD days_NNS )_) ,_, highest_JJS prothrombin_NN time_NN 16_CD ._. 7_CD ±_NN 3_CD ._. 0_CD s_VBZ on_IN day_NN 13_CD
          (_( ±_NN 28_CD days_NNS )_) ,_, highest_JJS total_JJ bilirubin_NN value_NN 6_CD ._. 9_CD ±_NN 6_CD ._. 3_CD mg_NN /_NN dl_NN
          on_IN day_NN 15_CD (_( ±_NN 34_CD days_NNS )_) ,_, highest_JJS creatinine_NN value_NN of_IN 1_CD ._. 9_CD ±_NN
          1_CD ._. 0_CD mg_NN /_NN dl_NN on_IN day_NN 13_CD (_( ±_NN 17_CD days_NNS )_) ,_, and_CC highest_JJS white_JJ blood_NN
          cell_NN count_NN of_IN 20547_CD ±_NN 8467_CD cells_NNS /_NN mm_NN 3_CD on_IN day_NN 9_CD (_( ±_NN 13_CD
          days_NNS )_) ._.
        
        
          Postoperative_NNP mortality_NN
          The_DT overall_JJ postoperative_JJ mortality_NN of_IN all_DT patients_NNS
          operated_VBN on_IN bythe_NN Hepatobiliary_NNP Surgical_NNP Service_NNP was_VBD 3_CD ._. 2_CD %_NN
          (_( 17_CD out_IN of_IN 537_CD patients_NNS )_) ._. Twelve_CD ofthe_NN 32_CD patients_NNS
          (_( 37_CD ._. 5_LS %_NN )_) admitted_VBN to_TO the_DT SCU_NNP during_IN their_PRP$ postoperative_JJ
          coursedied_JJ ,_, compared_VBN with_IN five_CD out_IN of_IN 505_CD (_( 1_CD ._. 0_CD %_NN )_) patients_NNS
          never_RB admitted_VBN to_TO the_DT SCUduring_NNP their_PRP$ postoperative_JJ
          course_NN (_( 
          P_NN <_NN 0_CD ._. 001_CD )_) ._. Neither_DT
          thepreoperative_JJ diagnosis_NN (_( Table_NNP 1_LS )_) nor_CC the_DT
          operationperformed_JJ (_( Table_NNP 2_LS )_) appear_VB to_TO be_VB associated_VBN with_IN
          an_DT increased_VBN risk_NN of_IN SCUdeath_NNP ._. At_IN the_DT time_NN of_IN death_NN ,_,
          eight_CD out_IN of_IN the_DT 12_CD patients_NNS (_( 67_CD %_NN )_) had_VBD
          respiratoryfailure_NN ,_, five_CD patients_NNS (_( 42_CD %_NN )_) had_VBD hepatic_JJ
          failure_NN ,_, and_CC three_CD patients_NNS (_( 25_CD %_NN )_) hadacute_NN renal_JJ failure_NN ._.
          Additionally_RB ,_, five_CD out_IN of_IN the_DT 12_CD patients_NNS (_( 42_CD %_NN )_)
          wereseptic_JJ ,_, two_CD patients_NNS (_( 17_CD %_NN )_) had_VBD persistent_JJ
          coagulopathy_NN and_CC ongoing_JJ uppergastrointestinal_NN bleeding_NN ,_,
          and_CC two_CD patients_NNS (_( 17_CD %_NN )_) died_VBD of_IN acute_JJ
          cardiopulmonaryarrest_NN of_IN undetermined_JJ etiology_NN ._. Overall_RB ,_,
          three_CD out_IN of_IN the_DT 12_CD patients_NNS (_( 25_CD %_NN )_) had_VBD multiple_JJ organ_NN
          system_NN failure_NN ._.
          Mean_VB total_JJ postoperative_JJ duration_NN of_IN stay_NN in_IN the_DT SCU_NNP
          wassignificantly_RB longer_RBR (_( 
          P_NN =_SYM 0_CD ._. 035_CD )_) for_IN nonsurvivors_NNS (_( 20_CD ._. 0_CD ±_NN
          23_CD ._. 8_CD days_NNS )_) than_IN for_IN survivors_NNS (_( 6_CD ._. 2_LS ±_NN 10_CD ._. 2_LS days_NNS )_) ._.
          Univariate_NNP analysisdemonstrated_JJ that_DT mortality_NN was_VBD
          significantly_RB increased_VBN for_IN patients_NNS who_WP hadmedian_NN total_JJ
          postoperative_JJ duration_NN of_IN stay_NN in_IN the_DT SCU_NNP that_WDT was_VBD
          greater_JJR thanthe_NN overall_JJ median_JJ duration_NN of_IN stay_NN of_IN 4_CD ._. 5_CD
          days_NNS (_( 
          P_NN =_SYM 0_CD ._. 009_CD )_) and_CC forpatients_NNS who_WP had_VBD
          more_JJR than_IN two_CD SCU_NNP admissions_NNS during_IN their_PRP$
          hospitalization_NN (_( 
          P_NN =_SYM 0_CD ._. 014_CD )_) ._. However_RB ,_, multivariate_NN
          analysis_NN of_IN these_DT variablessuggested_JJ that_IN only_RB a_DT median_JJ
          total_JJ postoperative_JJ duration_NN of_IN stay_NN in_IN the_DT SCU_NNP ofgreater_NN
          than_IN the_DT median_JJ total_JJ duration_NN of_IN stay_NN of_IN 4_CD ._. 5_CD days_NNS was_VBD an_DT
          independentpredictor_NN of_IN postoperative_JJ mortality_NN (_( 
          P_NN =_SYM 0_CD ._. 041_CD )_) ._. Postoperativemortality_NNP
          did_VBD not_RB depend_VB on_IN the_DT total_JJ postoperative_JJ duration_NN of_IN
          stay_NN ,_, or_CC on_IN thenumber_NN of_IN times_NNS a_DT patient_NN was_VBD taken_VBN to_TO the_DT
          operating_VBG room_NN ._.
          Preoperative_NNP and_CC intraoperative_JJ variables_NNS were_VBD
          analyzed_VBN (_( Table_NNP 4_CD as_IN potential_JJ predictors_NNS of_IN postoperative_JJ
          mortalityamong_NN patients_NNS admitted_VBN to_TO the_DT SCU_NNP ._. A_DT history_NN of_IN
          viral_JJ hepatitis_NN (_( 
          P_NN =_SYM 0_CD ._. 044_CD )_) was_VBD determined_VBN to_TO be_VB
          significantly_RB associated_VBN withpostoperative_JJ mortality_NN
          among_IN patients_NNS admitted_VBN to_TO the_DT SCU_NNP by_IN univariateanalysis_NNS ._.
          By_IN univariate_NN analysis_NN ,_, the_DT association_NN of_IN history_NN
          ofcirrhosis_NNS /_NN portal_NN hypertension_NN with_IN postoperative_JJ
          mortality_NN was_VBD determined_VBN toapproach_NN statistical_JJ
          significance_NN (_( 
          P_NN =_SYM 0_CD ._. 053_CD )_) among_IN patients_NNS admitted_VBD
          tothe_NN SCU_NNP ._. Multivariate_NNP analysis_NN of_IN those_DT two_CD variables_NNS
          revealed_VBD that_IN neither_DT ahistory_NN of_IN viral_JJ hepatitis_NN and_CC a_DT
          history_NN of_IN cirrhosis_NNS /_NN portal_NN hypertension_NN wasan_NN
          independent_JJ predictor_NN of_IN postoperative_JJ mortality_NN among_IN
          patients_NNS admitted_VBD tothe_NN SCU_NNP ._.
          Preoperative_NNP and_CC postoperative_JJ laboratory_NN values_NNS
          (_( mean_VB ±_NN standard_JJ deviation_NN )_) in_IN survivors_NNS (_( 
          n_NN =_SYM 20_CD )_) and_CC non-survivors_JJ (_( 
          n_NN =_SYM 12_CD )_) were_VBD analyzed_VBN as_IN potential_JJ
          predictors_NNS of_IN postoperative_JJ mortality_NN amongpatients_NNS
          admitted_VBN to_TO the_DT SCU_NNP (_( Table_NNP 5_LS )_) ._. In_IN
          nonsurvivorspreoperative_JJ prothrombin_NN time_NN was_VBD
          significantly_RB higher_JJR ,_, preoperative_JJ albuminwas_NNS nearly_RB
          significantly_RB lower_JJR (_( 
          P_NN =_SYM 0_CD ._. 056_CD )_) ,_, postoperative_JJ
          prothrombintime_NN was_VBD significantly_RB higher_JJR (_( 
          P_NN =_SYM 0_CD ._. 021_CD )_) ,_, postoperative_JJ albumin_NN
          levelswere_NN nearly_RB significantly_RB lower_JJR (_( 
          P_NN =_SYM 0_CD ._. 055_CD )_) ,_, and_CC postoperative_JJ
          whiteblood_NN cell_NN count_NN was_VBD significantly_RB higher_JJR (_( 
          P_NN =_SYM 0_CD ._. 020_CD )_) ._.
          Postoperative_NNP variables_NNS were_VBD analyzed_VBN as_IN potential_JJ
          predictors_NNS ofpostoperative_JJ mortality_NN among_IN patients_NNS
          admitted_VBN to_TO the_DT SCU_NNP (_( Table_NNP 6_CD )_) ._. By_IN univariate_NN analysis_NN ,_, a_DT
          patient_NN with_IN postoperativepneumonia_NN (_( 
          P_NN =_SYM 0_CD ._. 002_CD )_) ,_, hepatic_JJ failure_NN (_( 
          P_NN =_SYM 0_CD ._. 004_CD )_) ,_, orrespiratory_NN failure_NN (_(
          
          P_NN =_SYM 0_CD ._. 009_CD )_) was_VBD statistically_RB more_RBR
          likely_JJ to_TO diethan_NN patients_NNS with_IN other_JJ complications_NNS ._.
          However_RB ,_, multivariate_NN analysis_NN of_IN thesethree_NN
          postoperative_JJ complications_NNS failed_VBD to_TO disclose_VB any_DT
          independent_JJ predictorof_NN postoperative_JJ mortality_NN ._.
        
      
      
        Discussion_NNP
        There_EX is_VBZ relatively_RB incomplete_JJ information_NN available_JJ
        within_IN the_DT literature_NN as_IN to_TO the_DT causes_NNS and_CC outcomes_NNS of_IN
        utilization_NN of_IN critical_JJ care_NN services_NNS for_IN patients_NNS
        undergoing_VBG hepatobiliary_JJ surgery_NN ._. In_IN the_DT present_JJ paper_NN ,_, we_PRP
        have_VBP reviewed_VBN the_DT Memorial_NNP Sloan-_NNP Kettering_NNP Cancer_NNP Center_NNP
        experience_NN during_IN the_DT period_NN of_IN February_NNP 2_CD ,_, 1994_CD to_TO
        December_NNP 28_CD ,_, 1995_CD ._. Firstly_NNP ,_, this_DT study_NN was_VBD initiated_VBN to_TO
        help_VB to_TO determine_VB the_DT causes_NNS of_IN major_JJ morbidity_NN and_CC
        mortality_NN after_IN hepatobiliary_JJ surgery_NN ,_, such_JJ that_IN we_PRP might_MD
        alter_VB our_PRP$ patient_NN care_NN in_IN order_NN to_TO avoid_VB similar_JJ
        complications_NNS in_IN the_DT future_NN ._. Secondly_RB ,_, this_DT study_NN was_VBD
        initiated_VBN to_TO help_VB to_TO evaluate_VB possible_JJ predictors_NNS of_IN
        survival_NN once_RB a_DT major_JJ complication_NN had_VBD arisen_VBN ,_, such_JJ that_DT
        guidance_NN could_MD be_VB given_VBN to_TO clinicians_NNS caring_VBG for_IN such_JJ
        patients_NNS in_IN determining_VBG the_DT likelihood_NN of_IN ultimate_JJ survival_NN
        of_IN such_JJ events_NNS ._.
        Over_IN a_DT 23_CD -_: month_NN period_NN ,_, 6_CD ._. 0_CD %_NN of_IN patients_NNS operated_VBN upon_IN
        by_IN the_DT Hepatobiliary_NNP Surgical_NNP Service_NNP at_IN Memorial_NNP
        Sloan-_NNP Kettering_NNP Cancer_NNP Center_NNP required_VBD critical_JJ care_NN
        services_NNS ._. Information_NNP on_IN similar_JJ critical_JJ care_NN services_NNS
        utilized_JJ by_IN comparable_JJ hepatobiliary_JJ services_NNS at_IN other_JJ
        institutions_NNS is_VBZ not_RB available_JJ in_IN the_DT surgical_JJ literature_NN ;_:
        however_RB ,_, this_DT appears_VBZ to_TO be_VB an_DT appropriate_JJ level_NN of_IN care_NN ,_,
        because_IN the_DT mortality_NN of_IN patients_NNS treated_VBN postoperatively_RB
        with_IN floor_NN care_NN alone_RB was_VBD only_RB 1_CD %_NN (_( five_CD out_IN of_IN 505_CD
        patients_NNS )_) ._. The_DT fact_NN that_IN the_DT mortality_NN of_IN hepatobiliary_JJ
        patients_NNS ,_, once_RB admitted_VBN to_TO the_DT SCU_NNP ,_, was_VBD 37_CD ._. 5_LS %_NN (_( 12_CD out_IN of_IN 32_CD
        patients_NNS )_) may_MD be_VB taken_VBN to_TO suggest_VB that_IN patients_NNS might_MD have_VB
        been_VBN kept_VBN for_IN inappropriately_RB long_JJ periods_NNS on_IN floor_NN care_NN
        before_IN being_VBG admitted_VBN to_TO a_DT critical_JJ care_NN setting_NN ,_, or_CC that_IN
        the_DT problems_NNS that_WDT arose_VBD were_VBD poorly_RB treated_VBN in_IN the_DT critical_JJ
        care_NN setting_NN ,_, or_CC that_IN the_DT problems_NNS that_WDT arose_VBD were_VBD beyond_IN
        the_DT ability_NN of_IN critical_JJ care_NN medicine_NN to_TO salvage_VB ._. The_DT
        latter_JJ explanation_NN seems_VBZ to_TO be_VB the_DT most_RBS probable_JJ ._.
        The_DT causes_NNS for_IN admission_NN to_TO a_DT critical_JJ care_NN setting_VBG were_VBD
        varied_VBN ._. Three_CD findings_NNS from_IN the_DT present_JJ results_NNS appear_VBP to_TO
        be_VB worth_JJ further_JJ discussing_VBG ,_, however_RB ._. First_LS ,_, more_JJR than_IN 50_CD %_NN
        of_IN the_DT patients_NNS requiring_VBG a_DT SCU_NNP admission_NN suffered_VBD
        respiratory_JJ failure_NN ._. It_PRP is_VBZ possible_JJ that_IN instituting_VBG an_DT
        improved_VBN preoperative_JJ evaluation_NN of_IN pulmonary_JJ function_NN ,_, as_RB
        well_RB as_IN instituting_VBG a_DT pulmonary_JJ rehabilitation_NN program_NN ,_,
        might_MD help_VB to_TO reduce_VB this_DT excessive_JJ rate_NN of_IN respiratory_JJ
        failure_NN ._. Second_JJ ,_, the_DT intraoperative_JJ blood_NN loss_NN among_IN
        patients_NNS requiring_VBG a_DT SCU_NNP admission_NN was_VBD approximately_RB 2000_CD cm_NN
        3_CD and_CC the_DT intraoperative_JJ blood_NN transfusion_NN requirement_NN among_IN
        patients_NNS requiring_VBG a_DT SCU_NNP admission_NN was_VBD 3_CD ._. 4_CD units_NNS of_IN packed_VBN
        red_JJ blood_NN cells_NNS ._. Both_DT of_IN these_DT values_NNS are_VBP well_RB above_IN the_DT
        median_JJ values_NNS of_IN 645_CD cm_NN 3_CD of_IN intraoperative_JJ blood_NN loss_NN and_CC
        less_JJR than_IN one_CD unit_NN of_IN packed_VBN red_JJ blood_NN cells_NNS for_IN
        intraoperative_JJ blood_NN transfusion_NN recorded_VBN for_IN 496_CD patients_NNS
        undergoing_VBG hepatic_JJ resection_NN at_IN our_PRP$ own_JJ institution_NN [_NN 11_CD ]_NN ._.
        Third_NNP ,_, 10_CD out_IN of_IN 32_CD patients_NNS requiring_VBG a_DT SCU_NNP admission_NN
        underwent_VBD preoperative_JJ biliary_JJ drainage_NN procedures_NNS ,_, which_WDT
        is_VBZ above_IN the_DT rate_NN for_IN all_DT patients_NNS undergoing_VBG hepatobiliary_JJ
        surgery_NN ._. Our_PRP$ own_JJ institutional_JJ data_NNS have_VBP shown_VBN that_IN
        previously_RB drained_VBN patients_NNS with_IN tumors_NNS causing_VBG proximal_NN or_CC
        distal_NN obstruction_NN of_IN the_DT biliary_JJ tree_NN who_WP undergo_VBP surgical_JJ
        resection_NN or_CC surgical_JJ bypass_NN suffer_VB increased_VBN
        intraoperative_JJ blood_NN loss_NN [_NN 12_CD ]_NN ,_, as_RB well_RB as_IN increased_VBN
        postoperative_JJ infectious_JJ complications_NNS [_NN 13_CD ,_, 14_CD ,_, 15_CD ,_, 16_CD ]_NN ._.
        Those_DT organisms_NNS responsible_JJ for_IN the_DT postoperative_JJ
        infectious_JJ complications_NNS were_VBD the_DT same_JJ as_IN those_DT organisms_NNS
        isolated_VBN from_IN intraoperative_JJ bile_NN cultures_NNS [_NN 14_CD ,_, 16_CD ,_, 17_CD ,_,
        18_CD ]_NN ._. This_DT suggests_VBZ that_IN the_DT potential_JJ benefit_NN of_IN
        preoperative_JJ drainage_NN of_IN the_DT biliary_JJ tree_NN before_IN surgical_JJ
        resection_NN is_VBZ questionable_JJ and_CC needs_VBZ to_TO be_VB evaluated_VBN
        further_RB ._.
        On_IN univariate_NN analysis_NN ,_, we_PRP found_VBD an_DT association_NN of_IN a_DT
        history_NN of_IN viral_JJ hepatitis_NN with_IN postoperative_JJ mortality_NN (_( 
        P_NN =_SYM 0_CD ._. 044_CD )_) and_CC a_DT near_JJ association_NN of_IN
        a_DT history_NN of_IN cirrhosis_NNS (_( with_IN or_CC without_IN portal_NN
        hypertension_NN )_) with_IN postoperative_JJ mortality_NN (_( 
        P_NN =_SYM 0_CD ._. 053_CD )_) ._. These_DT findings_NNS confirm_VBP
        the_DT prior_JJ reports_NNS of_IN Bozzetti_NNP 
        et_CC al_NN [_NN 1_CD ]_NN and_CC Lehnert_NNP and_CC Herfarth_NNP [_NN
        19_CD ]_NN ._. Likewise_RB ,_, we_PRP found_VBD that_IN preoperative_JJ prothrombin_NN time_NN
        was_VBD significantly_RB (_( 
        P_NN =_SYM 0_CD ._. 025_CD )_) higher_JJR in_IN the_DT nonsurviving_VBG
        patients_NNS versus_CC the_DT surviving_VBG patients_NNS who_WP required_VBD
        postoperative_JJ critical_JJ care_NN utilization_NN ,_, and_CC preoperative_JJ
        albumin_NN was_VBD nearly_RB significantly_RB (_( 
        P_NN =_SYM 0_CD ._. 056_CD )_) lower_JJR in_IN the_DT nonsurviving_VBG
        patients_NNS versus_CC the_DT surviving_VBG patients_NNS who_WP required_VBD
        postoperative_JJ critical_JJ care_NN utilization_NN ._. These_DT findings_NNS
        confirm_VBP the_DT prior_JJ reports_NNS of_IN Nagino_NNP 
        et_CC al_NN [_NN 6_CD ]_NN ,_, Su_NNP 
        et_CC al_NN [_NN 7_CD ]_NN ,_, and_CC Lehnert_NNP and_CC Herfarth_NNP
        [_NN 19_CD ]_NN ._. Although_IN these_DT associations_NNS were_VBD not_RB independent_JJ
        predictors_NNS of_IN postoperative_JJ mortality_NN on_IN multivariate_NN
        analysis_NN ,_, these_DT associations_NNS suggest_VBP the_DT importance_NN of_IN
        hepatic_JJ function_NN and_CC hepatic_JJ reserve_NN in_IN pre-operative_JJ
        patient_NN selection_NN for_IN hepatobiliary_JJ surgery_NN ,_, as_IN has_VBZ been_VBN
        previously_RB established_VBN by_IN the_DT Child-_NNP Turcotte-_NNP Pugh_NNP grading_VBG
        system_NN for_IN severity_NN of_IN liver_NN disease_NN [_NN 20_CD ,_, 21_CD ]_NN ._. None_NN of_IN the_DT
        thirty-two_JJ patients_NNS requiring_VBG postoperative_JJ SCU_NNP admission_NN
        had_VBD ascites_NNS or_CC were_VBD encephalopathic_JJ preoperatively_RB ._.
        Therefore_RB ,_, preoperative_JJ prothrombin_NN time_NN and_CC preoperative_JJ
        albumin_NN ,_, as_RB well_RB as_IN a_DT history_NN of_IN viral_JJ hepatitis_NN and_CC /_NN or_CC a_DT
        history_NN of_IN cirrhosis_NNS with_IN or_CC without_IN portal_NN hypertension_NN ,_,
        may_MD be_VB taken_VBN to_TO indicate_VB a_DT need_NN for_IN heightened_VBN alertness_NNS to_TO
        the_DT possibility_NN of_IN the_DT need_NN for_IN critical_JJ care_NN services_NNS
        after_IN significant_JJ hepatobiliary_JJ surgery_NN ._.
        Once_RB admitted_VBN to_TO the_DT critical_JJ care_NN unit_NN ,_, postoperative_JJ
        mortality_NN increased_VBD with_IN increasing_VBG duration_NN of_IN stay_NN ,_, with_IN
        patients_NNS whose_WP$ SCU_NNP stays_VBZ exceeded_VBN 4_CD ._. 5_CD days_NNS doing_VBG
        significantly_RB worse_JJR ._. Beyond_IN this_DT association_NN of_IN survival_NN
        and_CC duration_NN of_IN SCU_NNP stay_VB ,_, we_PRP were_VBD unable_JJ to_TO establish_VB any_DT
        distinct_JJ individual_JJ markers_NNS to_TO help_VB determine_VB the_DT
        appropriateness_NN of_IN continuing_VBG aggressive_JJ care_NN of_IN critically_RB
        ill_JJ patients_NNS ._. However_RB ,_, if_IN markers_NNS could_MD be_VB identified_VBN ,_, then_RB
        the_DT determination_NN of_IN the_DT time_NN at_IN which_WDT aggressive_JJ critical_JJ
        care_NN becomes_VBZ futile_JJ could_MD be_VB established_VBN ._. This_DT would_MD
        ultimately_RB better_JJR assist_VB the_DT critical_JJ care_NN staff_NN in_IN
        advising_VBG the_DT patient_NN or_CC proxy_NN as_IN to_TO when_WRB survival_NN is_VBZ
        unlikely_JJ ,_, and_CC all_DT subsequent_JJ decisions_NNS about_IN pursuing_VBG
        further_JJ aggressive_JJ interventions_NNS could_MD be_VB made_VBN with_IN this_DT in_IN
        mind_NN ._.
      
    
  
